摘要
目的探讨血管介入治疗肺癌的疗效。方法 2012年12月至2014年3月间治疗的106例原发性肺癌患者进行血管介入治疗(介入组),并与同期90例行吉西他滨联合顺铂(GP)方案进行全身化疗的患者(GP组)进行比较,评价治疗后效果。结果介入组患者和完全缓解(CR)、部分缓解(PR)、疾病稳定(SD)及疾病进展(PD)均明显优于GP组,介入组和GP组的总有效率分别为80.2%和48.9%,介入组患者的不良反应发生率明显低于GP组。结论血管介入治疗在治疗肺癌中的应用具有很好的前景,可作为临床治疗肺癌的有效手段。
Objective To investigate the effect of interventional therapy in lung cancer.Methods Total of 106 cases with primary lung cancer were selected from December 2012 to March 2014 in Infectious Diseases Hospital of Liaocheng treated through vascular interventional therapy,compared with 90 patients in the same period treated with gemcitabine plus cisplatin（GP） scheme chemotherapy,and evaluated the therapeutic effect in two groups.Results After the vascular interventional treatment,complete response（CR）,partial response（PR）,stable disease（SD） and progressive disease（PD） were significantly better than that in GP group.The overall response rates were 80.2% and 48.9% in intervention group and chemotherapy group,respectively.The probability of adverse reactions in patients with intervention group was significantly lower than that in GP group.Conclusion Vascular intervention has very good prospect for application in the treatment of lung cancer,and it could be used as an effective means for clinical treatment of lung cancer.
出处
《中国肿瘤临床与康复》
2015年第1期34-36,共3页
Chinese Journal of Clinical Oncology and Rehabilitation
关键词
肺肿瘤
血管介入治疗
全身化疗
Lung neoplasms
Vascular interventional therapy
Systemic chemotherapy
